Philip Datlow

Philip Datlow is a Director and Senior IP Counsel at Boehringer Ingelheim USA Corporation located in Ridgefield, Connecticut. In his 16 years as IP counsel for Boehringer, Phil has drafted and prosecuted patent applications and strategically managed patent portfolios in a number of therapeutic areas within BI; prepared patent listing requests for the FDA’s Orange Book; conducted patentability and freedom to operate assessments; performed IP due diligence reviews; provided a wide range of licensing and agreement support, including negotiation of IP provisions for product in-licensing and out-licensing; assisted in developing best practices within BI for negotiation of IP provisions in agreements; and counseled on US export compliance issues.

Prior to joining BI, Phil was an associate attorney at the Sughrue, Mion law firm in Washington, DC handling patent prosecution and opinions. Prior to his tenure at Sughrue, Phil was a Patent Examiner at the U.S. Patent and Trademark Office, specializing in the area of nitrogen heterocyclic compounds and pharmaceuticals. Phil has a Bachelor of Science degree in organic chemistry from the University of Marlyand, and a law degree from the George Mason University School of Law.